393-11-3Nc1ccc([N+](=O)[O-])c(C(F)(F)F)c1UTKUVRNVYFTEHF-UHFFFAOYSA-Nmajor metabolite of flutamide
393-11-3DTXSID7057731This chemical does not meet GHS hazard criteria for 1.2% (1 of 81) of reports.
Danger
H301 (38.3%): Toxic if swallowed [Danger Acute toxicity, oral]
P261, P264, P264+P265, P270, P271, P280, P301+P316, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 (click each P-code to see the statement)
Aggregated GHS information provided per 81 reports by companies from 12 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
Status: Active Update: 25-05-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/21854
Benzenamine, 4-nitro-3-(trifluoromethyl)-: Does not have an individual approval but may be used as a component in a product covered by a group standard. It is not approved for use as a chemical in its own right.
Description4-Nitro-3-trifluoromethyl aniline is an organic intermediate, which can be used to prepare 4-bromo-2-nitrotrifluorotoluene, an intermediate of medicine and optical waveguide materials, and flutamide, a non steroidal anti androgen drug.
Uses4-Nitro-3-(trifluoromethyl)aniline is a metabolite of Flutamide (F598850) (FLU-1 or M2).
UsesA metabolite of Flutamide (FLU-1 or M2).
Loading…
CHEMBL3186805